Meet the ACDM27 Speaker
Claire Haslam
Director, Clinical Data & Information Sciences, Pfizer
Claire Haslam is a Director and Group Lead in Clinical Data Sciences at Pfizer, with more than 29 years of experience in clinical research spanning study management, project management, data management, and clinical data science. Throughout her career, she has been passionate about transforming how clinical trials are conducted, with a particular focus on applying risk-based approaches, critical thinking, and innovative data review strategies to improve trial quality, efficiency, and patient protection. Her work has centred on evolution from traditional, process-driven practices toward more evidence-based, data-centric decision making.
Claire is an active contributor to industry discussions on the future of clinical data science and the evolving role it plays in enabling risk-based data quality management. She has a particular interest in the evolution of Principal Investigator Data Oversight, exploring how digital technologies, metadata, workflow intelligence, and alternative evidence sources can be leveraged to demonstrate meaningful investigator engagement beyond traditional signatures and attestations. Through collaboration with sponsors, sites, and industry partners, she advocates for modern, proportionate oversight models that support both regulatory expectations and fit-for-purpose trial execution.


